Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Johnson & Johnson
Biotech
J&J, Protagonist's oral psoriasis prospect scores in phase 3s
The phase 3 successes pad the IL-23 blocker's case as J&J prepares to prove its worth against BMS' oral psoriasis treatment Sotyktu.
Zoey Becker
Nov 19, 2024 11:44am
J&J gets FDA OK to begin trials for its Ottava surgical robot
Nov 12, 2024 1:45pm
FDA approves J&J’s Varipulse pulsed field ablation system
Nov 7, 2024 3:00pm
TCT: Abiomed clears pivotal study for shrinkable heart pump
Oct 30, 2024 9:00am
J&J jettisons several programs, including ph. 2 Alzheimer's work
Oct 15, 2024 2:00pm
J&J posts adolescent myasthenia gravis data on $6B FcRn blocker
Oct 15, 2024 9:25am
